Romiplostim for the treatment of chronic immune thrombocytopenia

Technology appraisal guidance
Reference number: TA221
Published: 27 April 2011
Last updated: 26 October 2018

Evidence

Supporting evidence

Review decision
Review decision – November 2018
Review decision paper (PDF 310 KB)

Published:

09 November 2018
Matrix of stakeholders (PDF 256 KB)

Published:

09 November 2018